Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers In total, 64,839 men and women age 50 to 76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results